Company Number: 15155127

Analysis Date: 2025-07-19 12:07 UTC

1. Credit Opinion: DECLINE
   Rhema Therapy Ltd is a newly incorporated dormant company with minimal financial activity to date. The financial statements show nominal net assets of £30, reflecting only the initial share capital. There is no trading history, revenue, or cash flow data available to assess the company's ability to service debt or meet commercial obligations. Given the absence of operating performance and liquidity, the company currently lacks the financial substance needed to support credit facilities.

2. Financial Strength:
   The balance sheet is extremely limited, with total assets of £30 consisting entirely of cash and no liabilities. Net assets equal £30, representing the initial investment by the sole shareholder and director. There are no fixed assets or working capital beyond this amount. The company's dormant status means no revenue, profit, or retained earnings exist to indicate financial robustness.

3. Cash Flow Assessment:
   Cash held is minimal (£30), with no evidence of operating cash inflows or outflows. Working capital is positive by £30 but entirely reflects the initial capital injection. There is no track record of liquidity management, receivables, payables, or cash generation. The company has one employee (the director) and no operational activity reported.

4. Monitoring Points:

• Commencement of trading and revenue generation
• Cash flow statements and liquidity trends as operations begin
• Profitability and margin development once active
• Any changes in share capital or external financing arrangements
• Director and shareholder updates regarding business strategy and financial commitments